South Korea Peptide Therapeutics Market Size & Outlook
The peptide therapeutics market in South Korea is expected to reach a projected revenue of US$ 2,823.4 million by 2030. A compound annual growth rate of 14.7% is expected of South Korea peptide therapeutics market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,080.4
Forecast, 2030 (US$M)
$2,823.4
CAGR, 2024 - 2030
14.7%
Report Coverage
South Korea
South Korea peptide therapeutics market, 2018-2030 (US$M)
Related Markets
South Korea peptide therapeutics market highlights
- The South Korea peptide therapeutics market generated a revenue of USD 1,080.4 million in 2023 and is expected to reach USD 2,823.4 million by 2030.
- The South Korea market is expected to grow at a CAGR of 14.7% from 2024 to 2030.
- In terms of segment, metabolic disorders was the largest revenue generating application in 2023.
- Metabolic disorders is the most lucrative application segment registering the fastest growth during the forecast period.
Peptide therapeutics market data book summary
| Market revenue in 2023 | USD 1,080.4 million |
| Market revenue in 2030 | USD 2,823.4 million |
| Growth rate | 14.7% (CAGR from 2023 to 2030) |
| Largest segment | Metabolic disorders |
| Fastest growing segment | Metabolic disorders |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cancer, Metabolic disorders, Cardiovascular disorders, Respiratory disorders, Gastrointestinal disorders, Infectious disease, Pain, Dermatological disorders, Neurological disorders, Renal disorders |
| Key market players worldwide | Eli Lilly and Co, Pfizer Inc, Amgen Inc, Takeda Pharmaceutical Co Ltd, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Sanofi SA, Roche Holding AG, Novartis AG ADR, Novo Nordisk A/S ADR, GlaxoSmithKline, Ironwood Pharmaceuticals Inc Class A, Ipsen SA, Radius Health |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.1% of the global peptide therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China peptide therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 11,832.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Peptide Therapeutics Market Scope
Peptide therapeutics market segmentation & scope
Cancer
Metabolic disorders
Cardiovascular disorders
Respiratory disorders
Gastrointestinal disorders
Infectious disease
Pain
Dermatological disorders
Neurological disorders
Renal disorders
Others
Recombinant DNA Technology
Solid-Phase Peptide Synthesis (SPPS)
Hybrid
Liquid-Phase Peptide Synthesis (LPPS)
Others
Peptide Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea peptide therapeutics market size, by application, 2018-2030 (US$M)
South Korea Peptide Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
